10.57647/j.ijnd.2025.1604.25

Drug nanocrystals: A review of their application in the topical treatment of skin infections

  1. Programa de Pós-Graduação em Ciências Farmacêuticas - PPGCF, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brasil
  2. Programa de Pós-Graduação em Ciências Farmacêuticas - PPGCF  AND  Faculdade de Farmácia, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brasil
Drug nanocrystals: A review of their application in the topical treatment of skin infections

Received: 2025-01-20

Revised: 2025-04-14

Accepted: 2025-05-05

Published in Issue 2025-05-17

How to Cite

Felix Duarte, P. de A., Lima dos Santos, F., Kulkamp Guerreiro, I. C., & Vidor Contri, R. (2025). Drug nanocrystals: A review of their application in the topical treatment of skin infections. International Journal of Nano Dimension, 16(4 (October 2025). https://doi.org/10.57647/j.ijnd.2025.1604.25

PDF views: 232

Abstract

Drug nanocrystals, nano-sized delivery systems consisting of drug and stabilizers only, may be a valuable tool in the treatment of cutaneous infections, which remain a serious public health problem worldwide. This review aimed to compile scientific information published over the past 10 years on the topical use of nanocrystals for the treatment of cutaneous infections caused by fungi or bacteria (14 selected articles). Most articles synthesized nanocrystals by a top-down method, mainly the bead milling technique. After synthesis, nanocrystals were typically lyophilized and/or incorporated into a pharmaceutical formulation. The most used techniques for nanocrystal characterization were dynamic light scattering (particle size and polydispersity), electron microscopy (ultrastructural morphology) and high-performance liquid chromatography (solubility, dissolution, and drug release). A temperature of 4 °C was deemed optimal for storage. Several articles found that nanocrystals improved drug skin permeation and/or skin retention. Four articles conducted tests with fungi, nine articles with bacteria, and one article with fungi and bacteria, either in vitro or in vivo. In general, microbiological tests confirmed the greater effectiveness of nanocrystal formulations over conventional systems. The findings of this review demonstrate the potential of nanocrystals as safe and promising alternatives for the topical treatment of cutaneous infections caused by fungi or bacteria.

Keywords

  • Bacteria,
  • Cutaneous,
  • Fungi,
  • Infection,
  • Nanocrystals,
  • Nanotechnology,
  • Skin

References

  1. Watkins RR, David MZ. Approach to the Patient with a Skin and Soft Tissue Infection. Infect Dis Clin North Am 2021; 35:1–48. https://doi.org/10.1016/J.IDC.2020.10.011.
  2. Parmar PK, Wadhawan J, Bansal AK. Pharmaceutical nanocrystals: A promising approach for improved topical drug delivery. Drug Discov Today 2021; 26:2329–49. https://doi.org/10.1016/J.DRUDIS.2021.07.010.
  3. Singh B, Upadhyay PK, Kumar M. Nanocrystal for Dermatological Application: A Comprehensive Review. Curr Nanosci 2022;48–60. https://doi.org/10.2174/1573413717666210121143038.
  4. Patel V, Sharma OP, Mehta TA. Impact of Process Parameters on Particle Size Involved in Media Milling Technique Used for Preparing Clotrimazole Nanocrystals for the Management of Cutaneous Candidiasis. AAPS PharmSciTech 2019;20(5): 175. https://doi.org/10.1208/S12249-019-1368-1.
  5. dos Santos FL, Zilles JC, Machado AU, Marques MS, da Costa BS, Kulkamp Guerreiro IC, et al. Polymeric Nanocapsules Containing Ozonated Oil and Terbinafine Hydrochloride as a Potential Treatment Against Dermatophytes. AAPS PharmSciTech 2023; 24:1–12. https://doi.org/10.1208/s12249-023-02657-x
  6. Arunraj TR, Rejinold NS, Mangalathillam S, Saroj S, Biswas R, Jayakumar R. Synthesis, characterization and biological activities of curcumin nanospheres. J Biomed Nanotechnol 2014; 10:238–50. https://doi.org/10.1166/JBN.2014.1786.
  7. Lboutounne H, Chaulet JF, Ploton C, Falson F, Pirot F. Sustained ex vivo skin antiseptic activity of chlorhexidine in poly(ε-caprolactone) nanocapsule encapsulated form and as a digluconate. Journal of Controlled Release 2002; 82:319–34. https://doi.org/10.1016/S0168-3659(02)00142-6.
  8. Jain S, Jain SK, Khare P, Gulbake A, Bansal D, Jain SK. Design and development of solid lipid nanoparticles for topical delivery of an anti-fungal agent. Drug Deliv 2010; 17:443–51. https://doi.org/10.3109/10717544.2010.483252.
  9. Fernández-Campos F, Clares Naveros B, López Serrano O, Alonso Merino C, Calpena Campmany AC. Evaluation of novel nystatin nanoemulsion for skin candidosis infections. Mycoses 2013; 56:70–81. https://doi.org/10.1111/J.1439-0507.2012.02202.X.
  10. Jacobus Berlitz S, Reginatto P, Machado G da RM, Fuentefria AM, Morisso FDP, Contri RV, et al. Development of a Clioquinol Nanocarrier as a New, Promising Option for the Treatment of Dermatomycosis. Pharmaceutics 2023;15(2):531. https://doi.org/10.3390/PHARMACEUTICS15020531.
  11. Rukavina Z, Šegvić Klarić M, Filipović-Grčić J, Lovrić J, Vanić Ž. Azithromycin-loaded liposomes for enhanced topical treatment of methicillin-resistant Staphyloccocus aureus (MRSA) infections. Int J Pharm 2018; 553(1-2):109–19. https://doi.org/10.1016/J.IJPHARM.2018.10.024.
  12. Sadeghi B, Koupaei B. Biogenic Synthesis of Silver Nanoparticles Using Fruit Aqueous Extract of Psidium Guajava and Its Antibacterial Activity J Nanoanalysis 2017; 4:126-133. https://doi.org/10.22034/jna.2017.02.005
  13. Pourjafari M, Ghane M, Kaboosi H, Sadeghi B, Rezaei A. Antibacterial Properties of Ag-Cu Alloy Nanoparticles Against Multidrug-Resistant Pseudomonas aeruginosa Through Inhibition of Quorum Sensing Pathway and Virulence-Related Genes. J Biomed Nanotechnol 2022; 18(4):1196–1204. https://doi.org/10.1166/JBN.2022.3331.
  14. Parveen N, Abourehab MAS, Thanikachalam PV, Khar RK, Kesharwani P. Nanocrystals as an emerging nanocarrier for the management of dermatological diseases. Colloids Surf B Biointerfaces 2023;225:113231. https://doi.org/10.1016/J.COLSURFB.2023.113231.
  15. McGuckin MB, Wang J, Ghanma R, Qin N, Palma SD, Donnelly RF, et al. Nanocrystals as a master key to deliver hydrophobic drugs via multiple administration routes. J Control Release 2022;345:334–53. https://doi.org/10.1016/j.jconrel.2022.03.012
  16. Alnaim AS. Nanocrystals in Dermal Drug Delivery: A Breakthrough for Enhanced Skin Penetration and Targeted Skin Disorder Treatments. Pharmaceutics 2024; 16:1561. https://doi.org/10.3390/PHARMACEUTICS16121561.
  17. Giradkar V, Mhaske A, Shukla R. Nanocrystals: A Multifaceted Regimen for Dermatological Ailments. Particle & Particle Systems Characterization 2024; 41(6): 2300147. https://doi.org/10.1002/PPSC.202300147.
  18. Müller RH, Zhai X, Romero GB, Keck CM. Nanocrystals for passive dermal penetration enhancement. Springer Berlin Heidelberg; 2016. https://doi.org/10.1007/978-3-662-47862-2_18/FIGURES/6.
  19. Singh V, Bansal K, Bhati H, Bajpai M. New Insights into Pharmaceutical Nanocrystals for the Improved Topical Delivery of Therapeutics in Various Skin Disorders. Curr Pharm Biotechnol 2024; 25:1182–1198. https://doi.org/10.2174/0113892010276223231027075527
  20. Trousil J, Matejková J, Dai YS, Urbánek T, Šlouf M, Škorič M, et al. Nanocrystalline chloroxine possesses broad-spectrum antimicrobial activities and excellent skin tolerability in mice. 2022; 17:137–49. https://doi.org/10.2217/nnm-2021-0323
  21. Rofeal M, El-Malek FA, Qi X. In vitro assessment of green polyhydroxybutyrate/chitosan blend loaded with kaempferol nanocrystals as a potential dressing for infected wounds. Nanotechnology 2021;32(37). https://doi.org/10.1088/1361-6528/abf7ee
  22. Omolo CA, Kalhapure RS, Agrawal N, Rambharose S, Mocktar C, Govender T. Formulation and Molecular Dynamics Simulations of a Fusidic Acid Nanosuspension for Simultaneously Enhancing Solubility and Antibacterial Activity. Mol Pharm 2018; 15:3512–26. https://doi.org/10.1021/acs.molpharmaceut.8b00505
  23. Kumar M, Shanthi N, Mahato AK, Soni S, Rajnikanth PS. Preparation of luliconazole nanocrystals loaded hydrogel for improvement of dissolution and antifungal activity. Heliyon 2019;5 (5): e01688. https://doi.org/10.1016/j.heliyon.2019.e01688
  24. Ahmed IS, Elnahas OS, Assar NH, Gad AM, Hosary R El. Nanocrystals of Fusidic Acid for Dual Enhancement of Dermal Delivery and Antibacterial Activity: In Vitro, Ex Vivo and In Vivo Evaluation. Pharmaceutics 2020;12(3):199. https://doi.org/10.3390/pharmaceutics12030199
  25. Pyo SM, Hespeler D, Keck CM, Müller RH. Dermal miconazole nitrate nanocrystals - formulation development, increased antifungal efficacy & skin penetration. Int J Pharm 2017 ;531(1):350–9. https://doi.org/10.1016/j.ijpharm.2017.08.108
  26. Liu X, Fan H, Meng Z, Wu Z, Gu R, Zhu X, et al. Combined Silver Sulfadiazine Nanosuspension with Thermosensitive Hydrogel: An Effective Antibacterial Treatment for Wound Healing in an Animal Model. Int J Nanomedicine 2023; 18:679-691. https://doi.org/10.2147/ijn.s395004
  27. Liu X, Gan H, Hu C, Sun W, Zhu X, Meng Z, et al. Silver sulfadiazine nanosuspension-loaded thermosensitive hydrogel as a topical antibacterial agent. Int J Nanomedicine 2018; 14:289–300. https://doi.org/10.2147/ijn.s187918
  28. Permana AD, Paredes AJ, Volpe-Zanutto F, Anjani QK, Utomo E, Donnelly RF. Dissolving microneedle-mediated dermal delivery of itraconazole nanocrystals for improved treatment of cutaneous candidiasis. European Journal of Pharmaceutics and Biopharmaceutics 2020; 154:50–61. https://doi.org/10.1016/j.ejpb.2020.06.025
  29. Anjani QK, Sabri AH Bin, Domínguez-Robles J, Moreno-Castellanos N, Utomo E, Wardoyo LAH, et al. Metronidazole nanosuspension loaded dissolving microarray patches: An engineered composite pharmaceutical system for the treatment of skin and soft tissue infection. Biomaterials Advances 2022;140:213073. https://doi.org/10.1016/j.bioadv.2022.213073
  30. Najm MB, Rawas-Qalaji M, Assar NH, Yahia R, Hosary R El, Ahmed IS. Optimization, characterization and in vivo evaluation of mupirocin nanocrystals for topical administration. European Journal of Pharmaceutical Sciences 2022; 176:106251. https://doi.org/10.1016/j.ejps.2022.106251
  31. Gao L, Gan H, Meng Z, Gu R, Wu Z, Zhu X, et al. Evaluation of genipin-crosslinked chitosan hydrogels as a potential carrier for silver sulfadiazine nanocrystals. Colloids Surf B Biointerfaces 2016;148:343–53. https://doi.org/10.1016/j.colsurfb.2016.06.016
  32. Ji Y, Li H, Li J, Yang G, Zhang W, Shen Y, et al. Hair Follicle-Targeted Delivery of Azelaic Acid Micro/Nanocrystals Promote the Treatment of Acne Vulgaris. Int J Nanomedicine 2024; 19:5173–91. https://doi.org/10.2147/ijn.s459788
  33. Verma S, Kumar S, Gokhale R, Burgess DJ. Physical stability of nanosuspensions: Investigation of the role of stabilizers on Ostwald ripening. Int J Pharm 2011; 406(1-2):145–52. https://doi.org/10.1016/j.ijpharm.2010.12.027
  34. Mohammad IS, Hu H, Yin L, He W. Drug nanocrystals: Fabrication methods and promising therapeutic applications. Int J Pharm 2019; 562:187–202. https://doi.org/10.1016/j.ijpharm.2019.02.045
  35. Junghanns JUAH, Müller RH. Nanocrystal technology, drug delivery and clinical applications. Int J Nanomedicine 2008; 3(3):295–309. https://doi.org/10.2147/ijn.s595
  36. Romero GB, Keck CM, Müller RH. Simple low-cost miniaturization approach for pharmaceutical nanocrystals production. Int J Pharm 2016; 501(1-2):236–244. https://doi.org/10.1016/j.ijpharm.2015.11.047
  37. Chung NO, Lee MK, Lee J. Mechanism of freeze-drying drug nanosuspensions. Int J Pharm 2012; 437(1-2):42–50. https://doi.org/10.1016/j.ijpharm.2012.07.068
  38. Pelikh O, Stahr PL, Huang J, Gerst M, Scholz P, Dietrich H, et al. Nanocrystals for improved dermal drug delivery. European Journal of Pharmaceutics and Biopharmaceutics 2018; 128:170–178. https://doi.org/10.1016/j.ejpb.2018.04.020
  39. Falsafi SR, Rostamabadi H, Assadpour E, Jafari SM. Morphology and microstructural analysis of bioactive-loaded micro/nanocarriers via microscopy techniques; CLSM/SEM/TEM/AFM. Adv Colloid Interface Sci 2020; 280:102166. https://doi.org/10.1016/j.cis.2020.102166
  40. Hadgraft J, Lane ME. Skin permeation: The years of enlightenment. Int J Pharm 2005; 305 (1-2):2–12. https://doi.org/10.1016/j.ijpharm.2005.07.014
  41. Contri R V., Fiel LA, Alnasif N, Pohlmann AR, Guterres SS, Schäfer-Korting M. Skin penetration and dermal tolerability of acrylic nanocapsules: Influence of the surface charge and a chitosan gel used as vehicle. Int J Pharm 2016; 507(1-2):12–20. https://doi.org/10.1016/j.ijpharm.2016.03.046
  42. Percival SL, Emanuel C, Cutting KF, Williams DW. Microbiology of the skin and the role of biofilms in infection. Int Wound J 2012; 9(1):14–32. https://doi.org/10.1111/j.1742-481x.2011.00836.x
  43. Seedat N, Kalhapure RS, Mocktar C, Vepuri S, Jadhav M, Soliman M, et al. Co-encapsulation of multi-lipids and polymers enhances the performance of vancomycin in lipid-polymer hybrid nanoparticles: In vitro and in silico studies. Mater Sci Eng C Mater Biol Appl 2016; 61:616–630. https://doi.org/10.1016/j.msec.2015.12.053